161 related articles for article (PubMed ID: 36593009)
1. Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
Lee WS; Park SY; Park YL; Joo YE
In Vivo; 2023; 37(1):483-489. PubMed ID: 36593009
[TBL] [Abstract][Full Text] [Related]
2. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
3. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
4. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
5. Anterior Gradient 3 Promotes Breast Cancer Development and Chemotherapy Response.
Xu Q; Shao Y; Zhang J; Zhang H; Zhao Y; Liu X; Guo Z; Chong W; Gu F; Ma Y
Cancer Res Treat; 2020 Jan; 52(1):218-245. PubMed ID: 31291711
[TBL] [Abstract][Full Text] [Related]
6. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
[TBL] [Abstract][Full Text] [Related]
9. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
11. Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.
Obacz J; Brychtova V; Podhorec J; Fabian P; Dobes P; Vojtesek B; Hrstka R
Onco Targets Ther; 2015; 8():1523-32. PubMed ID: 26170690
[TBL] [Abstract][Full Text] [Related]
12. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
13. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology.
Boisteau E; Posseme C; Di Modugno F; Edeline J; Coulouarn C; Hrstka R; Martisova A; Delom F; Treton X; Eriksson LA; Chevet E; Lièvre A; Ogier-Denis E
Oncogene; 2022 Oct; 41(42):4673-4685. PubMed ID: 36068336
[TBL] [Abstract][Full Text] [Related]
14. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
15. AGR2 is associated with gastric cancer progression and poor survival.
Zhang J; Jin Y; Xu S; Zheng J; Zhang QI; Wang Y; Chen J; Huang Y; He X; Zhao Z
Oncol Lett; 2016 Mar; 11(3):2075-2083. PubMed ID: 26998125
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer.
Han YL; Chen L; Qin R; Wang GQ; Lin XH; Dai GH
World J Gastroenterol; 2019 Apr; 25(15):1828-1839. PubMed ID: 31057297
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
Zhao EH; Shen ZY; Liu H; Jin X; Cao H
World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
[TBL] [Abstract][Full Text] [Related]
20. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]